Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review Margriet IJzerman-KorevaarTom J. SnijdersFilip Y. F. de Vos Topic Review Open access 30 October 2018 Pages: 485 - 496
Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction Nathan B. RobertsAymen AlqazzazGraeme F. Woodworth Laboratory Investigation 21 August 2018 Pages: 497 - 507
Characterization of genomic alterations in primary central nervous system lymphomas Soheil ZorofchianHanadi El-AchiLeomar Y. Ballester Laboratory Investigation 31 August 2018 Pages: 509 - 517
KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma Michael J. CiesielskiYahao BuRobert A. Fenstermaker Laboratory Investigation 20 September 2018 Pages: 519 - 527
Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma Christine G. SkibinskiTara WilliamsonGregory J. Riggins Laboratory Investigation 09 November 2018 Pages: 529 - 538
Possible effects of radiofrequency electromagnetic fields on in vivo C6 brain tumors in Wistar rats Nihal S. OuadahAnthony LecomteAnne-Sophie Villégier Laboratory Investigation 12 November 2018 Pages: 539 - 546
Stereotactic radiosurgery for hypervascular intracranial tumors Cheng-Chia LeeChun-Lung ChouWen-Yuh Chung Clinical Study 20 August 2018 Pages: 547 - 558
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme Elisa De CarloLorenzo GerratanaSimona Rizzato Clinical Study 21 August 2018 Pages: 559 - 568
Platelet count is associated with outcome in cancer patients with stroke Bernardo Cacho-DíazHéctor Spínola-MaroñoMyrna Candelaria Clinical Study 18 August 2018 Pages: 569 - 574
A comparative analysis of clinicopathological features and survival among early adolescents/young adults and children with low-grade glioma: a report from the Children’s Oncology Group Ashley S. MargolKee Kiat YeoGirish Dhall Clinical Study 01 September 2018 Pages: 575 - 582
Diagnostic accuracy of MRI texture analysis for grading gliomas Austin DitmerBin ZhangAchala Vagal Clinical Study 25 August 2018 Pages: 583 - 589
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study Xiaojie DingZheng WangLiangfu Zhou Clinical Study 11 September 2018 Pages: 591 - 603
Cognitive functioning and functional brain networks in postoperative WHO grade I meningioma patients David van NieuwenhuizenLinda DouwArjan Hillebrand Clinical Study Open access 15 September 2018 Pages: 605 - 613
Gamma knife radiosurgery for recurrent gliomas Zjiwar H. A. SadikPatrick E. J. HanssensHilko Ardon Clinical Study Open access 06 September 2018 Pages: 615 - 622
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter? Joshua D. PalmerDeepak BhamidipatiWenyin Shi Clinical Study 04 September 2018 Pages: 623 - 628
Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience Cassie KlineS. John LiuSabine Mueller Clinical Study 11 September 2018 Pages: 629 - 638
Clinical and prognostic features of spinal meningioma: a thorough analysis from a single neurosurgical center Lingyang HuaHongda ZhuYe Gong Clinical Study 12 September 2018 Pages: 639 - 647
Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study Hwa Kyung ByunSeong YiChang-Ok Suh Clinical Study 10 September 2018 Pages: 649 - 657
Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients Hans-Georg WirschingJohannes Konstantin RichterMichael Weller Clinical Study 08 September 2018 Pages: 659 - 667
Prognosis and treatment outcomes of central neurocytomas: clinical interrogation based on a single center experience Joonho ByunSeok Ho HongChang Jin Kim Clinical Study 17 September 2018 Pages: 669 - 677
The prediction of the tumor size of a vestibular schwannoma by clinical performance and vestibular function tests Yujuan ZhouWeidong ZhaoJing Wang Clinical Study 20 September 2018 Pages: 679 - 686
Social cognition in patients with intracranial tumors: do we forget something in the routine neuropsychological examination? Simone GoebelH. Maximilian MehdornChristian D. Wiesner Clinical Study 21 September 2018 Pages: 687 - 696
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade Boris I. ChobrutskiySaif ZamanGeorge Blanck Clinical Study 31 October 2018 Pages: 697 - 704
Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer Bina KakusaSummer HanMelanie Hayden Gephart Clinical Study 20 November 2018 Pages: 705 - 715
Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the “head-start” I and II clinical trials Diana S. OsorioNeha PatelJonathan L. Finlay Clinical Study 03 November 2018 Pages: 717 - 725
Repeatability of dynamic contrast enhanced vp parameter in healthy subjects and patients with brain tumors Moran ArtziGilad LibermanDafna Ben Bashat Clinical Study 03 November 2018 Pages: 727 - 737
Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II–IV Kristin Marie Knudsen-BaasTom Børge JohannesenAnette Margrethe Storstein Clinical Study 23 November 2018 Pages: 739 - 748
Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases Ammoren E. DohmRyan HughesMichael D. Chan Clinical Study 26 October 2018 Pages: 749 - 756
The importance of adequate methotrexate and adequate folinic acid rescue doses in the treatment of primary brain lymphoma Ian J. Cohen Letter to the Editor 21 September 2018 Pages: 757 - 757
